Jason Denbo, MD
Surgical Oncology · Minneapolis, MNNPI 1346432572
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,000 of the $19,256 with a category attached, or 72.7%. Medtronic accounts for 83.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $13,332 and has fallen 88.6% since, to $1,520 in 2025.
Across 59 payments — averaging $326.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$16K
- Taiho Oncology, Inc.$2K
- Intera Oncology, Inc$447
- Histosonics, Inc.$401
- Integra Lifesciences Corporation$172
- Baxter Healthcare$156
- plus $487 from 6 others
Across 1 payment — averaging $63,959 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Delcath Systems$64K
What the payments were for
- Speaking & faculty fees$14,00073%
- Travel & lodging$4132%
- Food & beverage$4,84425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 40 | $16,094 |
| Taiho Oncology, Inc. | 1 | $1,500 |
| Intera Oncology, Inc | 3 | $447 |
| Histosonics, Inc. | 1 | $401 |
| Integra Lifesciences Corporation | 3 | $172 |
| Baxter Healthcare | 2 | $156 |
| Boston Scientific | 1 | $136 |
| Delcath Systems | 1 | $114 |
| Angiodynamics, Inc. | 1 | $111 |
| Intuitive Surgical | 3 | $67 |
| Covidien LP | 2 | $47 |
| Fresenius Kabi USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Signia$2,308
- INTERA$356
- DFS$167
- CODMAN CERTAS$161
- CUSA CLARITY$161
- CODMAN HAKIM$161
- DURASEAL EXACT SPINAL SEALANT SYSTEM$161
- LigaSure$153
- General - Interventional Oncology$136
- Hepzato Kit$114
How this compares
Too few surgical oncology providers in Minnesotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Minneapolis
- Eric JensenMinneapolis$221K
- David BrauerMinneapolis$6K
- Maria EvasovichMinneapolis$2K
- Jacob AnkenyMinneapolis$1K
- Christopher LaroccaMinneapolis$956
- Todd TuttleMinneapolis$653
- John ClarkMinneapolis$156
- Jane Yuet Ching HuiMinneapolis$0
- Jessica SteadmanRochester$2K
- Brian SparkmanSt Louis Park$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.